2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society.
Publication
, Journal Article
Kusumoto, FM; Schoenfeld, MH; Barrett, C; Edgerton, JR; Ellenbogen, KA; Gold, MR; Goldschlager, NF; Hamilton, RM; Joglar, JA; Kim, RJ; Lee, R ...
Published in: Circulation
August 20, 2019
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
August 20, 2019
Volume
140
Issue
8
Start / End Page
e333 / e381
Location
United States
Related Subject Headings
- Humans
- Genetic Testing
- Electrocardiography
- Cardiovascular System & Hematology
- Cardiotonic Agents
- Cardiac Conduction System Disease
- Calcium Channel Blockers
- Bronchodilator Agents
- Bradycardia
- Algorithms
Citation
APA
Chicago
ICMJE
MLA
NLM
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., … Varosy, P. D. (2019). 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. Circulation, 140(8), e333–e381. https://doi.org/10.1161/CIR.0000000000000627
Kusumoto, Fred M., Mark H. Schoenfeld, Coletta Barrett, James R. Edgerton, Kenneth A. Ellenbogen, Michael R. Gold, Nora F. Goldschlager, et al. “2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society.” Circulation 140, no. 8 (August 20, 2019): e333–81. https://doi.org/10.1161/CIR.0000000000000627.
Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. Circulation. 2019 Aug 20;140(8):e333–81.
Kusumoto, Fred M., et al. “2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society.” Circulation, vol. 140, no. 8, Aug. 2019, pp. e333–81. Pubmed, doi:10.1161/CIR.0000000000000627.
Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, Goldschlager NF, Hamilton RM, Joglar JA, Kim RJ, Lee R, Marine JE, McLeod CJ, Oken KR, Patton KK, Pellegrini CN, Selzman KA, Thompson A, Varosy PD. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. Circulation. 2019 Aug 20;140(8):e333–e381.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
August 20, 2019
Volume
140
Issue
8
Start / End Page
e333 / e381
Location
United States
Related Subject Headings
- Humans
- Genetic Testing
- Electrocardiography
- Cardiovascular System & Hematology
- Cardiotonic Agents
- Cardiac Conduction System Disease
- Calcium Channel Blockers
- Bronchodilator Agents
- Bradycardia
- Algorithms